Regen BioPharma RGBP
OTC RGBP
$0.00 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Regen BioPharma Inc (RGBP) Net Cash Flow (2013 - 2025)

Updated

Regen BioPharma (RGBP) recorded Net Cash Flow of -$64,977 in fiscal Q1 2026 (quarter ended Dec 31, 2025), compared with -$580.00 a year earlier.

Analysis

Regen BioPharma Inc (RGBP) Net Cash Flow (2013 - 2025) Analysis & Trends

On a TTM basis, Regen BioPharma's Net Cash Flow came in at $4,442 as of Dec 31, 2025; for FY2025 (ended Sep 30, 2025), it was $68,839.

  • Across earlier fiscal years, Net Cash Flow came in at -$120,321 in FY2024, $69,833 in FY2023, -$675,957 in FY2022 and $727,162 in FY2021.
  • The fiscal Q1 2026 figure is the lowest quarterly Net Cash Flow since fiscal Q3 2023.
  • Per Business Quant, the preceding three fiscal quarters came in at $67,794 (Q4 2025), -$1.00 (Q3 2025) and $1,626 (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -64,977.00
Sep 30, 2025 67,794.00
Jun 30, 2025 -1.00
Mar 31, 2025 1,626.00
Dec 31, 2024 -580.00
Sep 30, 2024 -61,132.00
Jun 30, 2024 -16,265.00
Mar 31, 2024 -46,385.00
Dec 31, 2023 3,461.00
Sep 30, 2023 120,345.00
Jun 30, 2023 -87,008.00
Mar 31, 2023 46,959.00
Dec 31, 2022 -10,463.00
Sep 30, 2022 -84,788.00
Jun 30, 2022 -123,681.00
Mar 31, 2022 -118,818.00
Dec 31, 2021 -373,670.00
Sep 30, 2021 538,983.00
Jun 30, 2021 188,179.00
Mar 31, 2020 -357.00
API Access

Regen BioPharma Inc Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=RGBP&period=max&api_key=YOUR_API_KEY